Publications by authors named "Chuangxin Lu"

Claim this Profile
A
Analysis and Exploration of the Relationship Between the Status of Serum Tumor Markers and Clinicopathological Features and Curative Effects in Gastric Cancer and Gastroesophageal Junction Tumor.
Yifan Xiao, Zhenzhu Xing, Zhaobing Li, Gang Jia, Peng Cheng, Chuangxin Lu

Onco Targets Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial.
Jia Liu, Jianwei Yang, Yuping Sun, Jifang Gong, Jinbo Yue, Chuangxin Lu, Yang Luo

Nat Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis and exploration of the association between serum tumor marker status and clinical pathological features, as well as efficacy, in colorectal cancer.
Zhenzhu Xing, Yifan Xiao, Shaobing Li, Gang Jia, Peng Cheng, Chuangxin Lu

Oncol Lett· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial.
Xiaotian Zhang, Jufeng Wang, Gang Wang, Yanqiao Zhang, Qingxia Fan, Chuangxin Lu, Changlu Hu, Jie Luo

JAMA· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockdown of circular RNA circ-FARSA restricts colorectal cancer cell growth through regulation of miR-330-5p/LASP1 axis.
Chuangxin Lu, Lei Fu, Xiaoyan Qian, Linsen Dou, Shundong Cang

Arch Biochem Biophys· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variants in the 3'-untranslated region of CUL3 is associated with risk of esophageal squamous cell carcinoma.
Jin-Long Hu, Xin-Long Hu, Chuang-Xin Lu, Xue-Jiao Chen, Lei Fu

J Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysaccharides isolated from Hedyotis diffusa inhibits the aggressive phenotypes of laryngeal squamous carcinoma cells via inhibition of Bcl-2, MMP-2, and μPA.
Caiqin Wu, Huanan Luo, Weijun Ma, Xiaoyong Ren, Chuangxin Lu

Gene· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of HOTAIR expression in colon cancer.
Zhi-Fen Luo, Dan Zhao, Xi-Qing Li, Yong-Xia Cui, Ning Ma, Chuang-Xin Lu

World J Gastroenterol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Feasibility analysis of endostatin combined with chemotherapy in the treatment of metastatic angiosarcoma].
Yongxia Cui, Zhifen Luo, Chuangxin Lu, Bing Bai

Zhonghua Zhong Liu Za Zhi· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysaccharide of Boschniakia rossica induces apoptosis on laryngeal carcinoma Hep2 cells.
Zhenghui Wang, Chuangxin Lu, Caiqin Wu, Min Xu, Xiaohui Kou

Gene· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quercetin enhances the effects of 5-fluorouracil-mediated growth inhibition and apoptosis of esophageal cancer cells by inhibiting NF-κB.
Lu Chuang-Xin, Wang Wen-Yu, Cui Yao, Li Xiao-Yan, Zhou Yun

Oncol Lett· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delisheng, a Chinese medicinal compound, exerts anti-proliferative and pro-apoptotic effects on HepG2 cells through extrinsic and intrinsic pathways.
Chuang-xin Lu, Ke-jun Nan, Yan-li Nie, Ya-nan Hai, Min Jiao

Mol Biol Rep· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells.
Tao Tian, Ke-Jun Nan, Shu-Hong Wang, Xuan Liang, Chuang-Xin Lu

Carcinogenesis· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
Tao Tian, Ke-Jun Nan, Hui Guo, Wen-Juan Wang, Zhi-Ping Ruan, Chuang-Xin Lu

Oncol Rep· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agents from amphibians with anticancer properties.
Chuang-Xin Lu, Ke-Jun Nan, Yan Lei

Anticancer Drugs· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WITHDRAWN: Treatment of combining antiangiogenic therapy and cytotoxic chemotherapy reduce the cancer stem-like cell fraction in hepatocarcinoma xenografts.
Shan-Yong Yi, Ke-Jun Nan, Feng Wang, Chuang-Xin Lu, Ying Kong

Biomed Pharmacother· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Small interfering RNA suppression of transducer and activator of transcription 3 (STAT3) signaling pathway: inhibitory effect on proliferation of human esophageal squamous carcinoma cells].
Xin-hua Wang, Shan-shan Li, Ai-hua Yan, Yang Sun, Chuang-xin Lu

Zhonghua Bing Li Xue Za Zhi· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Constitutive activation of signal transducers and activators of transcription 3 and expression of its target gene products in human ESCC cell line].
Xin-hua Wang, Shan-shan Li, Ai-hua Yan, Chuang-xin Lu, Yan-ping Guo

Nan Fang Yi Ke Da Xue Xue Bao· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis